Sulfhemoglobinemia
Sulfhemoglobinemia[edit | edit source]
Sulfhemoglobinemia is a rare condition characterized by the presence of sulfhemoglobin (SulfHb) in the blood. Sulfhemoglobin is an abnormal form of hemoglobin, the oxygen-carrying protein found in red blood cells, that has been irreversibly modified by the binding of a sulfur atom.
Etiology[edit | edit source]
- The primary cause of sulfhemoglobinemia is the exposure to drugs or substances that contain or can metabolize into sulfur. Such substances include:
- Sulfonamides
- Phenacetin
- Metoclopramide
- Nitrates
- Some antibiotics
- In rare cases, the condition can be idiopathic (without a known cause).
Clinical Manifestations[edit | edit source]
Patients with sulfhemoglobinemia often exhibit a characteristic cyanotic (blue-green) discoloration of the skin and mucous membranes, as sulfhemoglobin cannot effectively bind and carry oxygen. This can lead to hypoxia, although most patients do not usually have significant symptoms unless the SulfHb levels are quite high.
Diagnosis[edit | edit source]
Diagnosis of sulfhemoglobinemia is made by performing a blood test known as a methemoglobinemia and sulfhemoglobinemia blood test. This test differentiates between methemoglobin, a similarly modified form of hemoglobin, and sulfhemoglobin.
Treatment[edit | edit source]
There is currently no known treatment for sulfhemoglobinemia. The body cannot naturally break down sulfhemoglobin, so the condition is typically managed by identifying and removing the source of sulfur exposure. Over time, the body will naturally replace the modified red blood cells with normal ones.
Prognosis[edit | edit source]
In most cases, sulfhemoglobinemia is not life-threatening. However, severe or prolonged hypoxia can potentially result in organ damage, so individuals with this condition should be closely monitored.
See Also[edit | edit source]
References[edit | edit source]
- Mayo Clinic. (2023). Sulfhemoglobinemia. Retrieved from https://www.mayoclinic.org/sulfhemoglobinemia
- National Institutes of Health. (2023). Sulfhemoglobinemia. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK470/
- American Society of Hematology. (2023). Sulfhemoglobinemia. Retrieved from http://www.hematology.org/Patients/Blood-Disorders/Blood-Basics/5220.aspx
Sulfhemoglobinemia Resources | |
---|---|
|
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD